fda compounding semaglutide enforcement november 2025 news National Hispanic Medical Association FDA Drug Recalls and Warnings:

Our data suggest dynamic inverse regulation of GLP-1 and GLP-2 during liver regeneration, rather caused by an increase in expression/release than by changes in degradation capacity and might be associated with inflammatory responses

Eligible patients in Maryland and Delaware may receive in-person or telehealth care based on their location and clinical needs Some patients notice changes in appetite during the first few doses, while others require gradual dose escalation before experiencing a meaningful effect

Actual data from actual clinical trials, broken down so you can compare semaglutide and tirzepatide side by side and make a decision grounded in evidence rather than anxiety

Anyone with questions about the safety of their skin care routine should speak with a dermatologist

Here are my thoughts on combining intermittent fasting with the usage of GLP-1 medications

Poe and Corn, 2020)